Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

被引：23

作者：

Lacayo, Norman J. ^{[1
]}

Pullarkat, Vinod A. ^{[2
]}

Stock, Wendy ^{[3
]}

Jabbour, Elias ^{[4
]}

Bajel, Ashish ^{[5
]}

Rubnitz, Jeffrey ^{[6
]}

Leonard, Jessica ^{[7
]}

Mullighan, Charles G. ^{[6
]}

Khaw, Seong Lin ^{[8
]}

Vear, Susan I. ^{[9
]}

Opferman, Joseph T. ^{[10
]}

Salem, Ahmed Hamed ^{[11
]}

Schmidt, Michelle ^{[11
]}

Tong, Bo ^{[11
]}

Zhou, Lang ^{[11
]}

Ross, Jeremy A. ^{[11
]}

Bensman, Lindsey ^{[11
]}

Jacobson, Amanda ^{[11
]}

Norris, Robin ^{[12
]}

Alexander, Thomas ^{[13
]}

机构：

[1] Stanford Univ, Dept Pediat Hematol Oncol, Palo Alto, CA 94304 USA

[2] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA

[3] Univ Chicago, Chicago, IL 60637 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[5] Royal Melbourne Hosp, Parkville, Vic, Australia

[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA

[7] Oregon Hlth & Sci Univ, Dept Med Hematol Oncol, Portland, OR 97201 USA

[8] Royal Childrens Hosp, Parkville, Vic, Australia

[9] Nationwide Childrens Hosp, Pediat Hematol & Oncol, Columbus, OH USA

[10] St Jude Childrens Res Hosp, Dept Mol Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA

[11] AbbVie Inc, N Chicago, IL USA

[12] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA

[13] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-126977

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

285

引用

页数：4

共 50 条

[1] Safety and Efficacy of the BCL Inhibitors Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Hantel, Andrew
Wynne, Joseph
Lacayo, Norman
Khaw, Seong Lin
Rubnitz, Jeffrey
Mullighan, Charles
Schmidt, Michelle
Zhou, Ying
Ross, Jeremy A.
Rosenwinkel, Lindsey
Kim, Su Young
Jabbour, Elias
Alexander, Thomas
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S184 - S185
[2] Venetoclax and navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Pullarkat, Vinod A.
Lacayo, Norman J.
Jabbour, Elias
Rubnitz, Jeffrey E.
Bajel, Ashish
Laetsch, Theodore W.
Leonard, Jessica
Colace, Susan, I
Khaw, Seong Lin
Fleming, Shaun A.
Mattison, Ryan J.
Norris, Robin
Opferman, Joseph T.
Roberts, Kathryn G.
Zhao, Yaqi
Qu, Chunxu
Badawi, Mohamed
Schmidt, Michelle
Tong, Bo
Pesko, John C.
Sun, Yan
Ross, Jeremy A.
Vishwamitra, Deeksha
Rosenwinkel, Lindsey
Kim, Su Young
Jacobson, Amanda
Mullighan, Charles G.
Alexander, Thomas B.
Stock, Wendy
CANCER DISCOVERY, 2021, 11 (06) : 1440 - 1453
[3] Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Alexander, Thomas
Lacayo, Norman J.
Pullarkat, Vinod A.
Jabbour, Elias J.
Khaw, Seong Lin
Mullighan, Charles G.
Bajel, Ashish
Leonard, Jessica
Norris, Robin
Rubnitz, Jeffrey
Vear, Susan I.
Schmidt, Michelle
Tong, Bo
Zhou, Ying
Ross, Jeremy A.
Rosenwinkel, Lindsey
Jacobson, Amanda
Kim, Su Young
Stock, Wendy
BLOOD, 2018, 132
[4] Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Rubnitz, Jeffrey E.
Alexander, Thomas B.
Laetsch, Theodore W.
Khaw, Seong Lin
Pullarkat, Vinod A.
Opferman, Joseph T.
Roberts, Kathryn G.
Rosenwinkel, Lindsey
Tong, Bo
Pesko, John C.
Badawi, Mohamed
Vishwamitra, Deeksha
Kim, Su Young
Mullighan, Charles G.
Lacayo, Norman J.
BLOOD, 2020, 136
[5] Combination BCL-2 Inhibitor Therapy with Venetoclax and Navitoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Jabbour, Elias
Mullighan, Charles G.
Pullarkat, Vinod A.
Lacayo, Norman J.
Bajel, Ashish
Rubnitz, Jeffrey
Leonard, Jessica
Khaw, Seong Lin
Vear, Susan I.
Alexander, Thomas
Norris, Robin
Salem, Ahmed
Schmidt, Michelle
Tong, Bo
Zhou, Ying
Ross, Jeremy A.
Bensman, Lindsey
Jacobson, Amanda
Stock, Wendy
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S184 - S185
[6] Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
Bhatla, Teena
Hogan, Laura E.
Teachey, David T.
Bautista, Francisco
Moppett, John
Puyo, Pablo Velasco
Micalizzi, Concetta
Rossig, Claudia
Shukla, Neerav
Gilad, Gil
Locatelli, Franco
Baruchel, Andre
Zwaan, C. Michel
Bezler, Natalie S.
Rubio-San-Simon, Alba
Taussig, David C.
Raetz, Elizabeth A.
Mao, Zhengwei J.
Wood, Brent L.
Arias, Diana Alvarez
Krevvata, Maria
Nnane, Ivo
Bandyopadhyay, Nibedita
Solano, Lorena Lopez
Dennis, Robyn M.
Carson, Robin
Vora, Ajay
BLOOD, 2024, 144 (21)
[7] Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Place, Andrew E.
Karol, Seth E.
Forlenza, Christopher J.
Cooper, Todd M.
Fraser, Christopher
Cario, Gunnar
O'Brien, Maureen M.
Gerber, Nicolas U.
Bourquin, Jean-Pierre
Reinhardt, Dirk
Rubnitz, Jeffrey E.
Opferman, Joseph T.
Sunkersett, Gauri
Onishi, Maika
Dunshee, Diana R.
Chen, Xin
Unnebrink, Kristina
Vishwamitra, Deeksha
Dunbar, Fengjiao
Badawi, Mohamed
Ross, Jeremy A.
Loh, Mignon L.
PEDIATRIC BLOOD & CANCER, 2025,
[8] Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
El-Cheikh, Jean
Moukalled, Nour M.
El Darsa, Haidar
Massoud, Radwan
Kanj, Souha S.
Mahfouz, Rami
Bazarbachi, Ali
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : E441 - E444
[9] Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study
Karol, Seth E.
Cooper, Todd M.
Bittencourt, Henrique
Gore, Lia
O'Brien, Maureen M.
Fraser, Christopher
Gambart, Marion
Cario, Gunnar
Zwaan, Christian Michel
Bourquin, Jean-Pierre
Loh, Mignon L.
Caron, Hubert
Prine, Betty
Salem, Ahmed Hamed
Unnebrink, Kristina
Tong, Bo
Palenski, Tammy
Place, Andrew E.
BLOOD, 2019, 134
[10] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
Hidefumi Hiramatsu
Souichi Adachi
Katsutsugu Umeda
Itaru Kato
Lamis Eldjerou
Andrea Chassot Agostinho
Kazuto Natsume
Kota Tokushige
Yoko Watanabe
Stephan A. Grupp
International Journal of Hematology, 2020, 111 : 303 - 310

← 1 2 3 4 5 →